Novo Nordisk
NVO
#102
Rank
โ‚น15.207 T
Marketcap
โ‚น3,426
Share price
1.37%
Change (1 day)
-41.13%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2025 (TTM): โ‚น1.827 Trillion

According to Novo Nordisk's latest financial reports the company's current earnings are โ‚น47.70 Billion. , an increase over its 2024 earnings that were of โ‚น1.827 Trillion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2025

Annual earnings

Year Earnings Change
2025 โ‚น1.942 T6.28%
2024 โ‚น1.827 T28.01%
2023 โ‚น1.427 T57.81%
2022 โ‚น904.56 B5.24%
2021 โ‚น859.55 B12.38%
2020 โ‚น764.85 B13.11%
2019 โ‚น676.20 B-3.45%
2018 โ‚น700.36 B1.88%
2017 โ‚น687.42 B4.3%
2016 โ‚น659.06 B10.32%
2015 โ‚น597.39 B7.47%
2014 โ‚น555.89 B3.4%
2013 โ‚น537.60 B19.09%
2012 โ‚น451.44 B15.58%
2011 โ‚น390.59 B16.58%
2010 โ‚น335.05 B25.66%
2009 โ‚น266.64 B10.68%
2008 โ‚น240.91 B55.82%
2007 โ‚น154.61 B7.02%
2006 โ‚น144.47 B19.05%
2005 โ‚น121.35 B10.55%
2004 โ‚น109.76 B
2002 โ‚น75.49 B-14.39%
2001 โ‚น88.18 B-52.82%
2000 โ‚น186.89 B250%
1999 โ‚น53.39 B31.21%
1998 โ‚น40.69 B34.31%
1997 โ‚น30.29 B11.46%
1996 โ‚น27.18 B9.03%
1995 โ‚น24.93 B-3.15%
1994 โ‚น25.74 B-0.67%
1993 โ‚น25.91 B45.38%
1992 โ‚น17.82 B-13.81%
1991 โ‚น20.68 B37.12%
1990 โ‚น15.08 B-0.79%
1989 โ‚น15.20 B26.2%
1988 โ‚น12.04 B24.97%
1987 โ‚น9.63 B-0.9%
1986 โ‚น9.72 B-7.78%
1985 โ‚น10.54 B24.87%
1984 โ‚น8.44 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น944.29 B-51.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.384 T 22.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น713.34 B-63.27%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚น864.24 B-55.50%๐Ÿ‡บ๐Ÿ‡ธ USA